Modified T cells, pharmaceutical composition, manufacturing method thereof, and method of using the same

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11999968
APP PUB NO 20230131917A1
SERIAL NO

17508446

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This disclosure provides modified T cells possessing both cell killing function and antigen presenting cell function and method of culturing the same. By administration of the modified T cell, cancer cells in a subject may be effectively inhibited via cell-mediated immunity.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
FULLHOPE BIOMEDICAL CO LTD10F NO 10 LN 609 SEC 5 CHONGXIN RD SANGCHONG DIST NEW TAIPEI CITY 241

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chen, Li-Tzong Kaohsiung, TW 9 64
Cheng, Ya-Fang New Tapei, TW 8 22
Fang, Chih-Hao New Tapei, TW 6 0
Lee, Jan-Mou New Tapei, TW 11 9
Yu, Chun-Wei New Tapei, TW 34 66

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Dec 4, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Dec 4, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 4, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00